No causal association identified for human papillomavirus infections in lung cancer

Cancer Research

Volumn 74, Issue 13, 2014, Pages 3525-3534

  Anantharaman, Devasena ^a   Gheit, Tarik ^b   Waterboer, Tim ^g   Halec, Gordana ^g   Carreira, Christine ^c   Abedi Ardekani, Behnoush ^a,i   McKay Chopin, Sandrine ^b   Zaridze, David ^j   Mukeria, Anush ^j   Szeszenia Dabrowska, Neonila ^k   Lissowska, Jolanta ^l   Mates, Dana ^m   Janout, Vladimir ⁿ   Foretova, Lenka ^o   Bencko, Vladimir ^p   Rudnai, Peter ^q   Fabianova, Eleonora ^r   Tjønneland, Anne ^s   Travis, Ruth C ^t   Boeing, Heiner ^h   Ramon Quiros J ^v   Johansson, Mikael ^w   Krogh, Vittorio ^y   Bas Bueno De Mesquita, H ^u,z,aa   Kotanidou, Anastasia ^ab,ac   Clavel Chapelon, Fraņcoise ^d,e,f   Weiderpass, Elisabete ^x,ad,ae,af   Johansson, Mattias ^a   Pawlita, Michael ^g   Scelo, Ghislaine ^a   Tommasino, Massimo ^b   Brennan, Paul ^a   more..

^a Genetic Epidemiology Group   (United States)

^b Infections and Cancer Biology Group   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁱ N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^j NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^k INSTITUTE OF ONCOLOGY   (Poland)

^l NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

^m PALACKÝ UNIVERSITY   (Czech Republic)

ⁿ MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^o CHARLES UNIVERSITY   (Czech Republic)

^p NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^q Regional Authority of Public Health   (Slovakia)

^r DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^s UNIVERSITY OF OXFORD   (United Kingdom)

^t IMPERIAL COLLEGE LONDON   (United Kingdom)

^u Public Health Dir   (Spain)

^v Department of Radiation Sciences ^*  (Spain)

^w UMEÅ UNIVERSITY   (Sweden)

^x KAROLINSKA INSTITUTE   (Sweden)

^y NATIONAL CANCER INSTITUTE   (Italy)

^z NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^aa UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ab UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^ac BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ad UNIVERSITY OF TROMSØ   (Norway)

^ae CANCER REGISTRY OF NORWAY   (Norway)

^af FOLKHÄLSAN RESEARCH CENTER   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN E6; PROTEIN P16; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEROLOGY;

ADULT; AGED; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 6; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 84903973448     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3548     Document Type: Article

References (37)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008:GLOBOCAN2008. Int J Cancer 2010;127:2893-917.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002.CA Cancer J Clin 2005;55:74-108.
3. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007;7:778-90.
4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007;90:1-636.
5. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13:607-15.
6. Srinivasan M, Taioli E, Ragin CC. Human papillomavirus type 16 and 18 in primary lung cancers-a meta-analysis. Carcinogenesis 2009;30: 1722-8.
7. Koshiol J, Rotunno M, Gillison ML, Van Doorn LJ, Chaturvedi AK, Tarantini L, et al. Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst 2011;103:501-7.
8. Wang JL, Fang CL, Wang M, Yu MC, Bai KJ, Lu PC, et al. Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma. Int J Cancer 2014;134:65-71.
9. Herrero R. Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr 2003;(31):47-51.
10. Kashima HK, Shah F, Lyles A, Glackin R, Muhammad N, Turner L, et al. A comparison of risk factors in juvenile-onset and adultonset recurrent respiratory papillomatosis. Laryngoscope 1992; 102:9-13.
11. Shykhon M, Kuo M, Pearman K. Recurrent respiratory papillomatosis. Clin Otolaryngol Allied Sci 2002;27:237-43.
12. Li G, He L, Zhang E, Shi J, Zhang Q, Le AD, et al. Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1alpha and VEGF expression in non-small cell lung cancer cells. Cancer Lett 2011;311:160-70.
13. Willey JC, Broussoud A, Sleemi A, Bennett WP, Cerutti P, Harris CC. Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res 1991;51:5370-7.
14. Aguayo F, Castillo A, Koriyama C, Higashi M, Itoh T, Capetillo M, et al. Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer 2007;97:85-91.
15. Cheng YW, WuMF, Wang J, Yeh KT, Goan YG, Chiou HL, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 2007;67:10686-93.
16. Coissard CJ, Besson G, Polette MC,Monteau M, Birembaut PL, Clavel CE. Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 2005;18:1606-9.
17. Scelo G, Constantinescu V, Csiki I, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, et al. Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (europe). Cancer Causes Control 2004;15:445-52.
18. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26 Suppl 1:S6-14.
19. Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 2013;31:2708-15.
20. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, et al. Multiplex human papillomavirus serology based on in situpurified glutathione s-transferase fusion proteins. Clin Chem 2005;51: 1845-53.
21. Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S, et al. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev 2007;16:1874-9.
22. Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, et al. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 2008;4:e1000091.
23. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, et al. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006;44: 2025-31.
24. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006;44:504-12.
25. Smeets SJ, HesselinkAT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121:2465-72.
26. Halec G, Schmitt M, Dondog B, Sharkhuu E, Wentzensen N, Gheit T, et al. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 2013;132:63-71.
27. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366:991-8.
28. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772-83.
29. Anantharaman D, Gheit T, Waterboer T, Abedi-Ardekani B, Carreira C, McKay-Chopin S, et al. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst 2013;105:536-45.
30. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, KochWM,et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
31. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-20.
32. Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol 2011;40:489-502.
33. Szabo I, Sepp R, Nakamoto K, Maeda M, Sakamoto H, Uda H. Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 1994;73:2740-4.
34. Tsuhako K, Nakazato I, Hirayasu T, Sunakawa H, Iwamasa T. Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 1998;51:741-9.
35. Da J, Chen L, Hu Y. [Human papillomavirus infection and p53 gene mutation in primary lung cancer]. Zhonghua Zhong Liu Za Zhi 1996;18:27-9.
36. Zhang X, Zhu Y, Li L. [Point mutation of p53 and detection of human papillomavirus DNA in bronchogenic carcinoma]. Zhonghua Nei Ke Za Zhi 1995;34:673-5.
37. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001;61: 2799-803.